Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07269548
Recruiting Observational

Evaluation of the Healing of the Pilonidal Cyst After 1940 nm Laser Treatment

NCT07269548 · tracked via the Priya Life Science France tracker
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase
Observational
Started
2025-10-03
Last updated
2025-12-08

Condition(s) studied

Pilonidal Cyst/Fistula

Investigational drug(s) / intervention(s)

pilonidal cyst laser surgery

pilonidal cyst laser surgery: pilonidal cyst using 1940 nm laser treatment

Study summary

The aim of this study is to evaluate the extent to which the reduction of energy absorption that laser 1940 nm allows could improve the outcomes and postoperative results of the treatment of pilonidal cysts.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients who did not object to the collection of their data * Patients who underwent surgery for a pilonidal cyst using 1940 nm laser treatment Exclusion Criteria: * Patients with a history of pilonidal cyst surgery * Patients who underwent emergency surgery for an abscess * Patients already included in another therapeutic study protocol

Primary outcome measure(s)

  • HEALING — 1 Month
    The main objective is to evaluate the healing rate of the pilonidal sinus one month after treatment with Er-YAG laser 1940 nm. Wound healing at one month, defined by the absence of a dressing, is the main evaluation criterion.

Trial sites (1)

FacilityCityRegionStatus
Clinique de la Sauvegarde Lyon France Recruiting

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag) Recruiting
Study Comparing Two Anesthetics for Arthroscopic Rotator Cuff Repair Recruiting
Value of Capsular Repair for Latarjet Recruiting
Infiltration or Nerve Blocks in Addition to Adductor Canal Block Recruiting
Assessment of a 24-hour Preoperative Course of Antibiotic Therapy for Endoscopic Urological Surgery in Case of Positive Urine Culture Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07269548 on ClinicalTrials.gov ↗ ← All trials in France